Literature DB >> 15117875

Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism.

Kimberly J Land1, Jennifer S Moll, Mark H Kaplan, Gattadahalli S Seetharamaiah.   

Abstract

The role of T helper (Th) cells in experimental models of Graves' hyperthyroidism is still somewhat controversial. To further investigate the role of Th1- and Th2-dependent immunity during the development of Graves' hyperthyroidism, we tested mice with targeted deletion of signal transducer and activator of transcription-4 (Stat4) or Stat6 genes that, respectively, have impaired Th1 and Th2 immunity. We immunized wild-type BALB/c, Stat4(-/-), or Stat6(-/-) mice with human embryonic kidney cells (293 cells) expressing the extracellular domain of human TSH receptor (293-TBP cells). Fifty percent of wild-type BALB/c and Stat4(-/-) mice developed Graves' hyperthyroidism with elevated serum T(4) levels and thyroid stimulatory antibodies. In contrast, Stat6(-/-) mice resisted development of the disease. Stat4(-/-) mice exhibited a dominant Th2 immune response characterized by the production of IL-4 and IgG1 anti-TSH receptor antibodies. However, Stat6(-/-) mice displayed a strong Th1 immune response characterized by the production of interferon-gamma and IgG2a antibodies. Hyperthyroid mice showed enlargement of thyroid glands with hypertrophy and decreased amounts of colloid material, all characteristics of Graves' disease. These data demonstrate that in this model, Stat6-dependent Th2 immunity is critical for the development of Graves' hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117875     DOI: 10.1210/en.2004-0352

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

Review 1.  Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation.

Authors:  Yi-chi M Kong; Wei-Zen Wei; Yaron Tomer
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 2.  STAT4: a critical regulator of inflammation in vivo.

Authors:  Mark H Kaplan
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Environmental triggers of thyroiditis: hepatitis C and interferon-α.

Authors:  F Menconi; A Hasham; Y Tomer
Journal:  J Endocrinol Invest       Date:  2010-02-28       Impact factor: 4.256

Review 4.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

Review 5.  Interferon induced thyroiditis.

Authors:  Yaron Tomer; Francesca Menconi
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-12       Impact factor: 4.690

6.  Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.

Authors:  Yumiko Mizutori; Chun-Rong Chen; Francesco Latrofa; Sandra M McLachlan; Basil Rapoport
Journal:  J Clin Endocrinol Metab       Date:  2008-12-09       Impact factor: 5.958

7.  Hypothesis: sarcoidosis is a STAT1-mediated disease.

Authors:  James T Rosenbaum; Sirichai Pasadhika; Elliott D Crouser; Dongseok Choi; Christina A Harrington; Jinnell A Lewis; Carrie R Austin; Tessa N Diebel; Emily E Vance; Rita M Braziel; Justine R Smith; Stephen R Planck
Journal:  Clin Immunol       Date:  2009-05-22       Impact factor: 3.969

8.  High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups.

Authors:  Bahram Namjou; Andrea L Sestak; Don L Armstrong; Raphael Zidovetzki; Jennifer A Kelly; Noam Jacob; Voicu Ciobanu; Kenneth M Kaufman; Joshua O Ojwang; Julie Ziegler; Francesco P Quismorio; Andreas Reiff; Barry L Myones; Joel M Guthridge; Swapan K Nath; Gail R Bruner; Ruth Mehrian-Shai; Earl Silverman; Marisa Klein-Gitelman; Deborah McCurdy; Linda Wagner-Weiner; James J Nocton; Chaim Putterman; Sang-Cheol Bae; Yun Jung Kim; Michelle Petri; John D Reveille; Timothy J Vyse; Gary S Gilkeson; Diane L Kamen; Marta E Alarcón-Riquelme; Patrick M Gaffney; Kathy L Moser; Joan T Merrill; R Hal Scofield; Judith A James; Carl D Langefeld; John B Harley; Chaim O Jacob
Journal:  Arthritis Rheum       Date:  2009-04

9.  TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.

Authors:  Y Nagayama; O Saitoh; S M McLachlan; B Rapoport; H Kano; Y Kumazawa
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.